Binnopharm Group showed the highest growth on the pharmaceutical market in 2023

Binnopharm Group has become the leader in sales growth in the Russian market, significantly strengthening sales of its drugs in 2023. 


Binnopharm Group showed an increase of 24.5 % in value terms for 2023 among the TOP-10 corporations in the Russian pharmaceutical market. In absolute figures, the increase in sales amounted to more than RUB 8 billion, which is the best indicator of the retail segment (according to AlphaRM) and one of the best among the overall market. The company is steadily growing at a multiple of the market dynamics, increasing by 2.6 % in 2023 according to AlphaRM data.


Leading analytical agencies expect further strengthening of the sales growth trend of local players in 2024 as well (according to AlphaRM, DSM Group, IQVIA reports for 2023).